Lexaria Bioscience Corp (NASDAQ:LEXXW) — Market Cap & Net Worth
Market Cap & Net Worth: Lexaria Bioscience Corp (LEXXW)
Lexaria Bioscience Corp (NASDAQ:LEXXW) has a market capitalization of $11.23 ($11.23) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31809 globally and #6309 in its home market, demonstrating a -78.95% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lexaria Bioscience Corp's stock price $0.00 by its total outstanding shares 9362 (9.36K). Review Lexaria Bioscience Corp total liabilities to assess the company's total debt and financial obligations.
Lexaria Bioscience Corp Market Cap History: 2021 to 2026
Lexaria Bioscience Corp's market capitalization history from 2021 to 2026. Data shows change from $14.04K to $11.23 (-74.21% CAGR).
Lexaria Bioscience Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lexaria Bioscience Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Lexaria Bioscience Corp's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $14.04K | $722.74K | -$4.03 Million | 0.02x | N/A |
| 2022 | $3.74K | $255.40K | -$7.27 Million | 0.01x | N/A |
| 2023 | $4.21K | $226.21K | -$6.66 Million | 0.02x | N/A |
| 2024 | $7.15K | $464.28K | -$5.80 Million | 0.02x | N/A |
| 2025 | $39.32 | $705.92K | -$11.90 Million | 0.00x | N/A |
Competitor Companies of LEXXW by Market Capitalization
Companies near Lexaria Bioscience Corp in the global market cap rankings as of June 18, 2026.
Key companies related to Lexaria Bioscience Corp by market ranking:
- Advent Technologies Holdings Inc (NASDAQ:ADNWW): Ranked #31800 globally with a market cap of $28.99 USD.
- Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPHW): Ranked #31801 globally with a market cap of $27.81 USD.
- Aquis Exchange PLC (LSE:AQX): Ranked #31810 globally with a market cap of $10.66 USD ( GBX87.60K GBX).
- BriaCell Therapeutics Corp (NASDAQ:BCTXW): Ranked #31811 globally with a market cap of $8.79 USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #31800 | Advent Technologies Holdings Inc | NASDAQ:ADNWW | $28.99 | $0.00 |
| #31801 | Reviva Pharmaceuticals Holdings Inc | NASDAQ:RVPHW | $27.81 | $0.00 |
| #31810 | Aquis Exchange PLC | LSE:AQX | $10.66 | GBX0.00 |
| #31811 | BriaCell Therapeutics Corp | NASDAQ:BCTXW | $8.79 | $0.00 |
Lexaria Bioscience Corp Historical Marketcap From 2021 to 2026
Between 2021 and today, Lexaria Bioscience Corp's market cap moved from $14.04K to $ 11.23, with a yearly change of -74.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.23 | -71.43% |
| 2025 | $39.32 | -99.45% |
| 2024 | $7.15K | +69.80% |
| 2023 | $4.21K | +12.53% |
| 2022 | $3.74K | -73.34% |
| 2021 | $14.04K | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Lexaria Bioscience Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.23 USD |
| MoneyControl | $11.23 USD |
| MarketWatch | $11.23 USD |
| marketcap.company | $11.23 USD |
| Reuters | $11.23 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lexaria Bioscience Corp
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall … Read more